Department of Molecular Medicine and Surgery, Karolinska Institutet, Rolf Luft Center for Diabetes and Endocrinology, Karolinska Hospital, Stockholm, Sweden.
Diabetes Metab Res Rev. 2011 Jul;27(5):470-9. doi: 10.1002/dmrr.1203.
Increased production of reactive oxygen species (ROS) in mitochondria has been proposed as the pathogenic mechanism for chronic complications of diabetes. Mitochondrial DNA (mtDNA) is more vulnerable to reactive oxygen species. However, there are few data on the mitochondrial DNA damage in diabetes and these are available only from patients with different duration of the disease and tissues not relevant to the chronic complications of diabetes. We therefore proposed to study the stability of mitochondrial DNA under controlled experimental conditions, to understand its contribution to chronic complications of diabetes.
The mitochondrial DNA damage was evaluated by long-fragment polymerase chain reaction in human dermal fibroblasts exposed to high glucose level and hypoxia (an additional source of reactive oxygen species) or in organs from diabetic animals (db/db mice) at different ages. Reactive oxygen species production was assessed in vitro by fluorescence and in vivo by nitrosylation of the proteins. The antioxidant enzymes were assessed by enzyme activity and by quantitative real-time polymerase chain reaction while the mitochondrial repair activity (base excision repair) was determined by using abasic site-containing oligonucleotides as substrates.
Hyperglycaemia, when combined with hypoxia, is able to induce mitochondrial DNA damage in human dermal fibroblasts. The deleterious effect is mediated by mitochondrial reactive oxygen species, being abolished when the mitochondria electron transport is blocked. The accumulation of mitochondrial DNA damage in vivo is, however, decreased in 'old' diabetic animals (db/db) despite higher reactive oxygen species levels. This mitochondrial DNA protection might be conferred by an increased base excision repair activity.
Increased base excision repair activity in tissues affected by the chronic complications of diabetes is a potential mechanism that can overcome mitochondrial DNA damage induced by hyperglycaemia-related reactive oxygen species overproduction.
线粒体中活性氧(ROS)的产生增加被认为是糖尿病慢性并发症的发病机制。线粒体 DNA(mtDNA)更容易受到活性氧的影响。然而,关于糖尿病中线粒体 DNA 损伤的数据很少,而且这些数据仅来自疾病持续时间不同且与糖尿病慢性并发症无关的组织的患者。因此,我们建议在受控实验条件下研究线粒体 DNA 的稳定性,以了解其对糖尿病慢性并发症的贡献。
通过长片段聚合酶链反应评估暴露于高葡萄糖水平和缺氧(活性氧的另一个来源)或不同年龄的糖尿病动物(db/db 小鼠)器官中的人真皮成纤维细胞中线粒体 DNA 的损伤。通过荧光法在体外评估活性氧的产生,通过蛋白质的硝化作用在体内评估。通过酶活性和定量实时聚合酶链反应评估抗氧化酶,通过使用含有碱基缺失的寡核苷酸作为底物来确定线粒体修复活性(碱基切除修复)。
高血糖与缺氧结合能够诱导人真皮成纤维细胞中线粒体 DNA 损伤。有害作用是由线粒体活性氧介导的,当线粒体电子传递被阻断时,该作用被消除。然而,尽管活性氧水平较高,但“年老”糖尿病动物(db/db)体内线粒体 DNA 损伤的积累减少。这种线粒体 DNA 保护可能是由于碱基切除修复活性增加所致。
糖尿病慢性并发症相关组织中增加的碱基切除修复活性是一种潜在的机制,可以克服由高血糖相关活性氧过度产生引起的线粒体 DNA 损伤。